Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and CapecitabineEdith A. Perez, Gabriel N. Hortobágyi, Xavier Pivot et al.|Journal of Clinical Oncology|2007Cited by 392
Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survivalDenise A. Yardley, Linda D. Bosserman|Breast Cancer Research|2015Cited by 46